Zivo Bioscience Inc
General ticker "ZIVO" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $66.9M
Zivo Bioscience Inc follows the US Stock Market performance with the rate: 40.5%.
Estimated limits based on current volatility of 7.8%: low 18.09$, high 21.17$
Factors to consider:
- Current price 677.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.51$, 2.84$]
- 2024-12-30 to 2025-12-30 estimated range: [0.42$, 1.78$]
Financial Metrics affecting the ZIVO estimates:
- Negative: Non-GAAP EPS, $ of -3.90 <= 0.10
- Negative: Operating profit margin, % of -99.62 <= 1.03
- Negative: Operating cash flow per share per price, % of -77.28 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0.62 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of 3.20 <= 3.85
Short-term ZIVO quotes
Long-term ZIVO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.03MM |
| Operating Expenses | $8.65MM | $8.73MM | $7.29MM |
| Operating Income | $-8.65MM | $-8.73MM | $-7.26MM |
| Non-Operating Income | $-0.11MM | $-0.01MM | $-0.51MM |
| Interest Expense | $0.23MM | $0.01MM | $0.51MM |
| R&D Expense | $2.12MM | $2.24MM | $1.38MM |
| Income(Loss) | $-8.76MM | $-8.75MM | $-7.78MM |
| Profit(Loss) | $-8.76MM | $-8.75MM | $-7.78MM |
| Stockholders Equity | $6.04MM | $-0.01MM | $-2.21MM |
| Assets | $8.99MM | $2.12MM | $0.56MM |
| Operating Cash Flow | $-6.80MM | $-7.10MM | $-5.80MM |
| Financing Cash Flow | $15.57MM | $0.00MM | $4.28MM |
| Earnings Per Share* | $-7.40 | $-5.58 | $-4.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.